Font Size: a A A
Keyword [? blocker]
Result: 121 - 140 | Page: 7 of 10
121. Experimental Study On Effect Of Adrenergic Blocker On Postresuscitation Myocardial Dysfunction In Rabbits
122. The Diversitication Of Renal Pelvis Pressure Under The Infection Of A-adrenoreceptor Blocker
123. Endothelial Function And Platelet Activation In Patients With Non-valvular Atrial Fibrillation And The Influence Of Beta-blocker On Them
124. Effect Of ARB On Expression Of NF-kB And PPARγ In Adipose Tissue Of Rats On Long-term High-fat-diet
125. Clinical Analysis Of 51 Cases Of Dilated Cardiomyopathy In Children
126. The Survey On The Effect Of Initial Periodontal Therapy To Druginduced Gingival Overgrowth
127. Impact Of DTPA-DG On Hexokinase Phosphorylation And A GLUT-specific Blocking Agent
128. Research On The Influence Of Smoking To The Therapeutice Effects Of Terazosin,Amlodipine And The Combination
129. Vasomotion In Resistance Vessel From Spontaneously Hypertensive Rat And Its Response To Antihypertensive Agents
130. Clinical Research Of Alpha-Blocker Treating Chronic Prostatitis
131. Preparation And Study Of Alfuzosin Hydrochloride Orally Disintegrating Tablets
132. Protective Effect Of Mitochondrial ATP-sensitive Potassium Channel Opener Together With Na+/Ca2+ Exchanging Blocker On Myocardial Ischemia-reperfusion Injury In Isolated Rat Hearts
133. Angiotensin Receptor Blocker Affects AT-1 And AT-2 Expression In AMI Rat
134. A Survey Of β Blocker's Use In Patients Of Chronic Systolic Heart Failure Or Coronary Heart Disease
135. The Role Of Renin-Angiotensin System Blockade Therapy In The Prevention Of Atrial Fibrillation: A Meta-Analysis Of Randomized Controlled Trials
136. Long-term Treatment Of Angiotensin-converting Enzyme Inhibitors Versus Calcium Channel Blockers In Preventing The Progression Of The Diabetic Nephropathy: A Meta-analysis
137. Retinal Neovascularization Is Prevented By Blockade Of The Renin-Angiotensin System
138. The Combination Of RAS Blocker Plus Sympathetic Blocking Agent Or Renal Denervation Is Superior To RAS Blocker Or Sympathetic Blocking Agent Monotherapy In The Rat Renal Ablation Model
139. The Effect Of Esmolol On PP And MAP In CHD With Hypertension
140. Renoprotective Effects Of RAS Blockers And Calcium Channel Blocker In Alone Or In Combination
  <<First  <Prev  Next>  Last>>  Jump to